These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

504 related articles for article (PubMed ID: 24462659)

  • 1. Arsenic exposure and bladder cancer: quantitative assessment of studies in human populations to detect risks at low doses.
    Tsuji JS; Alexander DD; Perez V; Mink PJ
    Toxicology; 2014 Mar; 317():17-30. PubMed ID: 24462659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-level arsenic exposure in drinking water and bladder cancer: a review and meta-analysis.
    Mink PJ; Alexander DD; Barraj LM; Kelsh MA; Tsuji JS
    Regul Toxicol Pharmacol; 2008 Dec; 52(3):299-310. PubMed ID: 18783726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bladder/lung cancer mortality in Blackfoot-disease (BFD)-endemic area villages with low (<150 μg/L) well water arsenic levels--an exploration of the dose-response Poisson analysis.
    Lamm SH; Robbins SA; Zhou C; Lu J; Chen R; Feinleib M
    Regul Toxicol Pharmacol; 2013 Feb; 65(1):147-56. PubMed ID: 23137931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bayesian benchmark dose analysis for inorganic arsenic in drinking water associated with bladder and lung cancer using epidemiological data.
    Shao K; Zhou Z; Xun P; Cohen SM
    Toxicology; 2021 May; 455():152752. PubMed ID: 33741492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk assessment of arsenic-induced internal cancer at long-term low dose exposure.
    Liao CM; Shen HH; Chen CL; Hsu LI; Lin TL; Chen SC; Chen CJ
    J Hazard Mater; 2009 Jun; 165(1-3):652-63. PubMed ID: 19062162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Environmental risk assessment of arsenic and fluoride in the Chaco Province, Argentina: research advances.
    Buchhamer EE; Blanes PS; Osicka RM; Giménez MC
    J Toxicol Environ Health A; 2012; 75(22-23):1437-50. PubMed ID: 23095162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arsenic concentrations in prediagnostic toenails and the risk of bladder cancer in a cohort study of male smokers.
    Michaud DS; Wright ME; Cantor KP; Taylor PR; Virtamo J; Albanes D
    Am J Epidemiol; 2004 Nov; 160(9):853-9. PubMed ID: 15496537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of mode of action data to inform a dose-response assessment for bladder cancer following exposure to inorganic arsenic.
    Gentry PR; Yager JW; Clewell RA; Clewell HJ
    Toxicol In Vitro; 2014 Oct; 28(7):1196-205. PubMed ID: 24937311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discontinuity in the cancer slope factor as it passes from high to low exposure levels--arsenic in the BFD-endemic area.
    Lamm SH; Robbins S; Chen R; Lu J; Goodrich B; Feinleib M
    Toxicology; 2014 Dec; 326():25-35. PubMed ID: 25241138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative assessment of lung and bladder cancer risk and oral exposure to inorganic arsenic: Meta-regression analyses of epidemiological data.
    Lynch HN; Zu K; Kennedy EM; Lam T; Liu X; Pizzurro DM; Loftus CT; Rhomberg LR
    Environ Int; 2017 Sep; 106():178-206. PubMed ID: 28625818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arsenic in drinking water and urinary tract cancers: a systematic review of 30 years of epidemiological evidence.
    Saint-Jacques N; Parker L; Brown P; Dummer TJ
    Environ Health; 2014 Jun; 13():44. PubMed ID: 24889821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arsenic exposure in US public and domestic drinking water supplies: a comparative risk assessment.
    Kumar A; Adak P; Gurian PL; Lockwood JR
    J Expo Sci Environ Epidemiol; 2010 May; 20(3):245-54. PubMed ID: 19401722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ingested arsenic, characteristics of well water consumption and risk of different histological types of lung cancer in northeastern Taiwan.
    Chen CL; Chiou HY; Hsu LI; Hsueh YM; Wu MM; Chen CJ
    Environ Res; 2010 Jul; 110(5):455-62. PubMed ID: 19735913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bladder cancer and arsenic through drinking water: a systematic review of epidemiologic evidence.
    Christoforidou EP; Riza E; Kales SN; Hadjistavrou K; Stoltidi M; Kastania AN; Linos A
    J Environ Sci Health A Tox Hazard Subst Environ Eng; 2013; 48(14):1764-75. PubMed ID: 24007431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arsenic in drinking water and risk of urinary tract cancer: a follow-up study from northeastern Taiwan.
    Chen CL; Chiou HY; Hsu LI; Hsueh YM; Wu MM; Wang YH; Chen CJ
    Cancer Epidemiol Biomarkers Prev; 2010 Jan; 19(1):101-10. PubMed ID: 20056628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arsenic cancer risk posed to human health from tilapia consumption in Taiwan.
    Liao CM; Shen HH; Lin TL; Chen SC; Chen CL; Hsu LI; Chen CJ
    Ecotoxicol Environ Saf; 2008 May; 70(1):27-37. PubMed ID: 18068227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arsenic: bioaccessibility from seaweed and rice, dietary exposure calculations and risk assessment.
    Brandon EF; Janssen PJ; de Wit-Bos L
    Food Addit Contam Part A Chem Anal Control Expo Risk Assess; 2014; 31(12):1993-2003. PubMed ID: 25393691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimating the risk of bladder and kidney cancer from exposure to low-levels of arsenic in drinking water, Nova Scotia, Canada.
    Saint-Jacques N; Brown P; Nauta L; Boxall J; Parker L; Dummer TJB
    Environ Int; 2018 Jan; 110():95-104. PubMed ID: 29089168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of cancer risk and environmental levels of arsenic in New Hampshire.
    Karagas MR; Stukel TA; Tosteson TD
    Int J Hyg Environ Health; 2002 Mar; 205(1-2):85-94. PubMed ID: 12018020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P53 alterations in bladder tumors from arsenic and tobacco exposed patients.
    Moore LE; Smith AH; Eng C; DeVries S; Kalman D; Bhargava V; Chew K; Ferreccio C; Rey OA; Hopenhayn C; Biggs ML; Bates MN; Waldman FM
    Carcinogenesis; 2003 Nov; 24(11):1785-91. PubMed ID: 12919957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.